drugset / Trial / NCT01951950

Nicardipine vs Esmolol Craniotomy Emergence

NCT01951950

Phase 1 Completed 40 enrolled Northwestern University
RandomizedParallel-groupOpen-labelTreatment

Summary

Emergence hypertension is a common occurrence in patients emerging from general anesthesia. This elevation of arterial pressure is particularly concerning in patients undergoing craniotomy due to increased risk of morbidity and mortality in patients with altered intracranial elastance. Thus, identifying better methods to attenuate the hemodynamic changes associated with emergence from anesthesia can improve patient safety, especially in the neurosurgical patient. Study Hypothesis: Nicardipine is more effective than esmolol as a sole agent in maintaining blood pressure within goal range in the setting of emergence hypertension after craniotomy.

Timeline

Start
2013-09
Primary completion
2014-05
Completion
2014-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Esmolol Other / unclassified 50 ug/kg Other
Comparator Nicardipine Small molecule 5 mg Other

Indications